Article Information
History
- April 15, 2022.
Article Versions
- Version 1 (April 12, 2022 - 23:12).
- You are viewing Version 2, the most recent version of this article.
Copyright
The copyright holder for this preprint is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. All rights reserved. No reuse allowed without permission.
Author Information
- Stefan Groha1,2,13,
- Sarah Abou Alaiwi3,
- Wenxin Xu5,
- Vivek Naranbhai5,
- Amin H. Nassar3,4,
- Ziad Bakouny4,5,
- Elio Adib3,4,
- Pier V. Nuzzo3,6,
- Andrew L. Schmidt5,
- Chris Labaki5,
- Talal El Zarif3,5,
- Biagio Ricciuti8,
- Joao Victor Alessi8,
- David A. Braun3,
- Sachet A. Shukla2,5,7,
- Tanya E. Keenan2,5,9,
- Eliezer Van Allen2,5,10,
- Mark M. Awad8,
- Michael Manos5,
- Osama Rahma4,5,
- Leyre Zubiri11,
- Alexandra-Chloe Villani2,12,13,
- Christian Hammer17,
- Zia Khan17,
- Kerry Reynolds13,14,
- Yevgeniy Semenov15,
- Deborah Schrag1,
- Kenneth L. Kehl1,
- Matthew L. Freedman2,5,*,
- Toni K. Choueiri3,4,5,13,* and
- Alexander Gusev1,2,13,16,*,‡
- 1Division of Population Sciences, Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA, USA
- 2Broad Institute of Harvard & MIT, Cambridge, MA, USA
- 3Lank Center for Genitourinary Oncology, Dana-Farber Cancer Institute, Boston, MA, USA
- 4Department of Medicine, Brigham and Women’s Hospital, Boston, MA, USA
- 5Department of Medical Oncology, Dana-Farber Cancer Institute, Harvard Medical School, Boston, MA, USA
- 6Department of Internal Medicine and Medical Specialties (DIMI), School of Medicine, University of Genoa, Genoa, Italy
- 7Translational Immunogenomics Lab, Dana-Farber Cancer Institute, Boston, MA, USA
- 8Lowe Center for Thoracic Oncology, Dana-Farber Cancer Institute, Boston, MA, USA
- 9Breast Oncology Program, Dana-Farber/Brigham and Women’s Cancer Center, Boston, MA, USA
- 10Center for Cancer Precision Medicine, Dana-Farber Cancer Institute, Boston, MA, USA
- 11Massachusetts General Hospital, Boston, MA, USA
- 12Center for Immunology and Inflammatory Diseases, Department of Medicine, Massachusetts General Hospital, Boston, MA, USA
- 13Harvard Medical School, Boston, MA, USA
- 14Division of Medical Oncology, Bartlett, Massachusetts General Hospital, Boston, MA, USA
- 15Department of Dermatology, Massachusetts General Hospital, Boston, MA, USA
- 16Division of Genetics, Brigham and Women’s Hospital, Boston, MA, USA
- 17Genentech, South San Francisco, CA, USA
- ↵‡Corresponding; email: alexander_gusev{at}dfci.harvard.edu
↵* Equal contribution
Posted April 15, 2022.
